VIRAHEP-C: A STUDY OF ANTIVIRAL RESISTANCE IN AFR AMER/CAUCASIAN-HEP C

这个子项目是利用由NIH/NCRR资助的中心拨款提供的资源的许多研究子项目之一。子项目和调查员(PI)可能从另一个NIH来源获得了主要资金，因此可能会出现在其他CRISE条目中。列出的机构是针对中心的，而不一定是针对调查员的机构。这项研究的目的是测试这种药物的安全性和有效性，比较非裔美国人和高加索丙型肝炎患者对抗病毒治疗的反应差异，并了解为什么可能会有反应差异。此外，在定期研究访问期间获得的血液样本也将用于额外的研究，以进行特别的丙型肝炎测试，以检查为什么一些患者对治疗没有反应。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to test the safety and effectiveness of this medication, and to compare differences in how African American and Caucasian patients with hepatitis C respond to antiviral therapy and to learn why there may be differences in response. In addition, blood samples that will be obtained during the regular study visits will also be used for additional studies for special hepatitis C testing to examine why some patients do not respond to treatment.